Status:
COMPLETED
Validation of a Tool for the Dimensional Assessment of Apathy in a Population Suffering From Schizophrenia.
Lead Sponsor:
Centre Hospitalier de Niort
Conditions:
Schizophrenia
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Schizophrenia affects about 1% of the world's population. According to the WHO, it was one of the ten most worrying pathologies of the twenty-first century. The situation of psychic disability that re...
Eligibility Criteria
Inclusion
- Men or women between 18 and 55 years old
- According to the DSM-5 criteria: spectrum of schizophrenia and other psychotic disorders (excluding psychotic disorder induced by a substance, drug or other medical condition as well as schizotypal personality disorder) in relation to the medical file and confirmed by the MINI test.
- Stable symptomatology (clinical assessment) during the month prior to inclusion
- Substantive psychotropic treatment unchanged during the month prior to inclusion (25% change).
- Reading and writing in French acquired.
- Persons who received informed information about the study and who co-signed, with the investigator, a consent to participate in the study
- After signing the consent by persons under guardianship, signed consent for participation by the tutor.
- For persons under guardianship, signature of the consent under the curator's assistance.
- Affiliate or Social Security Entitlement
Exclusion
- IQ score \< 70 (intellectual disability measured by f-NA)
- Neurological disorders of vascular, infectious or neurodegenerative origin, dyschromatopsia.
- Taking somatic drugs with a cerebral or mental impact (eg corticosteroids).
- Resistance to neuroleptics.
- Addiction to cannabis, alcohol or other substances (\> 2 / week) according to DSM-5 criteria, except tobacco.
- Simultaneous participation in a remediation program targeting neurocognitive deficits.
- Refusal of consent of the person.
- For persons under guardianship: refusal of consent of the legal representative for participation in this study.
- For persons under curatorship: no information of the legal representative for participation in this study.
Key Trial Info
Start Date :
July 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 22 2020
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT03801551
Start Date
July 3 2018
End Date
October 22 2020
Last Update
October 23 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Esquirol
Limoges, France, 87025
2
Centre Hospitalier de Niort
Niort, France, 79021